Excerpted from the recent book contribution by Senior Fellow Dr. Russell M. Jaffe, MD, Ph.D., CCN investigating the use of bioactive food as a therapeutic intervention for the treatment of diabetes, this chapter focuses on how diabetes can be an immune dysfunction.
Diabetes afflicts over 250 million people worldwide. Impaired glucose tolerance affects millions. This trend is projected to add an additional 220 millions before 2050. While diabetes kills too many and accounts for about half of disease care costs, it is a choice. Newly developed ultra-low glycemic balanced 200 calorie meals provide better options that can maintain healthier blood sugar levels for hours after consumption through higher fiber and nutrient dense ingredients.